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Adherent-invasive Escherichia coli (AIEC) strains are overrepresented in the dysbiotic
microbiota of Crohn’s disease (CD) patients, and contribute to the onset of the chronic
inflammation typical of the disease. However, the effects of anti-inflammatory drugs
used for CD treatment on AIEC virulence have not yet been investigated. In this
report, we show that exposure of AIEC LF82 strain to amino-6-mercaptopurine (6-
MP) riboside, one of the most widely used anti-inflammatory drugs in CD, impairs
its ability to adhere to, and consequently to invade, human epithelial cells. Notably,
phagocytosis of LF82 treated with 6-MP by human macrophages is also reduced,
suggesting that 6-MP affects AIEC cell surface determinants involved both in interaction
with epithelial cells and in uptake by macrophages. Since a main target of 6-MP in
bacterial cells is the inhibition of the important signal molecule c-di-GMP, we also tested
whether perturbations in cAMP, another major signaling pathway in E. coli, might have
similar effects on interactions with human cells. To this aim, we grew LF82 in the
presence of glucose, which leads to inhibition of cAMP synthesis. Growth in glucose-
supplemented medium resulted in a reduction in AIEC adhesion to epithelial cells and
uptake by macrophages. Consistent with these results, both 6-MP and glucose can
affect expression of cell adhesion-related genes, such as the csg genes, encoding
thin aggregative fimbriae (curli). In addition, glucose strongly inhibits expression of the
fim operon, encoding type 1 pili, a known AIEC determinant for adhesion to human
cells. To further investigate whether 6-MP can indeed inhibit c-di-GMP signaling in
AIEC, we performed biofilm and motility assays and determination of extracellular
polysaccharides. 6-MP clearly affected biofilm formation and cellulose production, but
also, unexpectedly, reduced cell motility, itself an important virulence factor for AIEC. Our
results provide strong evidence that 6-MP can affect AIEC-host cell interaction by acting
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on the bacterial cell, thus strengthening the hypothesis that mercaptopurines might
promote CD remission also by affecting gut microbiota composition and/or physiology,
and suggesting that novel drugs targeting bacterial virulence and signaling might be
effective in preventing chronic inflammation in CD.
Keywords: adherent-invasive E. coli, Crohn’s disease, azathioprine, 6-mercaptopurines, c-di-GMP, dysbiosis,
virulence factors
INTRODUCTION
Crohn’s disease (CD), a type of inflammatory bowel disease
(IBD), is characterized by chronic and relapsing intestinal
inflammation resulting from inappropriate and persistent
activation of the mucosal immune system (de Souza and Fiocchi,
2016). The pathophysiology of CD is determined by a variety
of elements, including heritable traits (Duerr et al., 2006;
Villani et al., 2009), environmental factors (Ng et al., 2013),
abnormalities in the intestinal mucosal barrier (Wang et al.,
2016), and aberrant immune response (Geremia et al., 2014).
However, there is increasing evidence pointing to dysbiosis,
i.e., an altered composition of the normal gut microbiota
resulting in a breakdown of host–microbial mutualism, as a key
factor in CD pathogenesis (Ahmed et al., 2016). Indeed, the
shift from predominant symbiont microorganisms to potential
harmful “pathobiont” microbes has been well documented in
IBD by various clinical studies (Frank et al., 2007; Kaur et al.,
2011). Metagenomic analyses of human gut microbiota in
IBD patients have also revealed hallmark shifts in microbial
abundances in comparison to healthy individuals, characterized
in particular by an enrichment in pathobionts from Bacteroidetes
and enterobacteria and a concomitant depletion of symbionts
including Firmicutes, Bifidobacteria, and Clostridia (Walters
et al., 2014; Gevers et al., 2017). Conversely, for other bacterial
genera, results from metagenomic analyses comparing healthy
subjects and CD patients have not always provided consistent
results, due for instance to the comparison of very diverse
samples such as human fecal rather than mucosal microbiota
(Zoetendal et al., 2002). However, despite some differences,
the whole of metagenomic data points to the importance of a
relatively small group of pathogenic microorganisms in setting
off the onset of CD (Bull et al., 2003; Laharie et al., 2009). In
particular, adherent-invasive Escherichia coli (AIEC) are enriched
in ileal specimens from CD patients, in comparison to non-
IBD patients; remarkably, however, AIEC were rarely found in
samples from ulcerative colitis (UC) patients (Boudeau et al.,
1999; Darfeuille-Michaud et al., 2004; Martinez-Medina et al.,
2009). The important role played by AIEC in CD pathogenicity
is due to their ability to invade both intestinal epithelial
cells and macrophages, in turn resulting in high levels of
secretion of pro-inflammatory cytokines ultimately contributing
to chronic inflammation (Glasser et al., 2001; Eaves-Pyles et al.,
2008).
6-Mercaptopurines (6-MP) have been used for several decades
as anti-inflammatory drugs in IBD treatment, to counteract
chronic inflammation (Lennard, 1992). Azathioprine, the 6-MP
drug most commonly employed in therapy, is metabolically
activated and converted into thioguanine nucleotides (TGN),
which are ultimately responsible for its anti-inflammatory
activity. In particular, azathioprine metabolite 6-thioguanosine-
triphosphate (6-T-GTP) has been shown to prevent Rac1
and Rac2 activation in human CD4+ lymphocytes blocking
T-cell activation (Tiede et al., 2003), and also to inhibit Rac1
in macrophages and intestinal epithelial cells, thus reducing
their inflammation and proliferation (Marinkovic et al., 2014).
However, in addition to its activity on the immune system cells,
azathioprine also shows some antibacterial activity, for instance
against Mycobacterium avium subspecies paratuberculosis
(MAP), the etiological agent of chronic granulomatous enteritis
in cattle (Johne’s disease), which bears some resemblance to
human CD (Shin and Collins, 2008). Interestingly, several
published studies have indicated that MAP, similarly to
AIEC, is present in higher amounts in CD patients than in
UC patients and non-inflammatory IBD (Feller et al., 2007;
Abubakar et al., 2008) suggesting a possible important role for
these bacteria in CD immunopathology. In a previous work,
we showed that azathioprine can inhibit biosynthesis of the
signal molecule c-di-GMP in the E. coli MG1655 laboratory
strain, possibly via inhibition of de novo purine biosynthesis
(Antoniani et al., 2013). c-di-GMP controls the synthesis of
various highly antigenic extracellular structures in bacteria
(Cotter and Stibitz, 2007), and is also a powerful effector of
the human immune response (Karaolis et al., 2007; Gray et al.,
2012), suggesting that inhibition of c-di-GMP synthesis in
bacteria might tone down its immunostimulatory effect, relieving
inflammation. Altogether, these observations suggest that the
anti-inflammatory activity of 6-MP might target not only human
macrophages, epithelial cells, and lymphocytes, but also the
gut microbiota, by impacting either growth or physiological
conditions (or both) of bacteria linked to CD. However, the
direct effect of 6-MP on AIEC-virulence factors has never been
characterized.
In this work, we show that the AIEC strain LF82, grown in the
presence of amino-6-MP riboside, a metabolite of azathioprine,
is affected in its ability to attach and, consequently to invade
human epithelial cells. We also analyzed 6-MP effects on AIEC
virulence in the presence of glucose, and those of glucose alone.
Indeed, in the ileal mucosa, i.e., the site where AIEC is found
with higher frequency in CD patients, glucose concentrations can
vary considerably, reaching higher concentrations than in the
bloodstream (Holst et al., 2016). Transient exposure to glucose
might modulate production of AIEC virulence determinants, as
reported for other pathogens (Munson, 2013; Daddaoua et al.,
2014; Rossi et al., 2016). Finally, while 6-MP is an inhibitor
of c-di-GMP, glucose strongly represses cAMP production in
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E. coli, thus affecting another important nucleotide-derived
signal molecule. We found that pre-growth of AIEC in glucose-
supplemented medium impaired adhesion to epithelial cells and
uptake by macrophages, to an extent similar to 6-MP, likely via
inhibition of cAMP biosynthesis. Our results strongly suggest
that targeting bacterial–host interaction might represent an
important strategy for the development of novel therapeutics
aimed at the remission and treatment of CD.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, and Growth
Conditions
The LF82 strain used in this study was originally isolated from
an ileal biopsy specimen from a CD patient (Boudeau et al.,
1999). As a non-AIEC control, the standard laboratory strain
MG1655 (Blattner et al., 1997) was used in our experiments.
Bacteria were growth either in YESCA medium (10 g/l casamino
acids, 1.5 g/l yeast extract) or in YESCA medium supplemented
with 0.2% (11.1 mM) glucose (YESCA-GLU). 6-MP was added at
either 2 µg/ml (6.7 µM) to liquid cultures or 8 µg/ml (26.7 µM)
to cultures grown on solid medium. These concentrations are
subinhibitory for growth in the different conditions, as the
minimal inhibitory concentration (MIC) of 6-MP in YESCA
liquid medium is 64 µg/ml (213 µM) (Supplementary Figure 1).
In order to perturb intracellular c-di-GMP concentrations, LF82
was transformed either with pTOPOAdrA (referred to as pAdrA
from now on) (Gualdi et al., 2008), for the overexpression
of the diguanylate cyclase-encoding adrA gene (Zogaj et al.,
2001), or with the pTOPODosP, to overexpress the dosP
gene, coding for a c-di-GMP phosphodiesterase (referred to
as pDosP from now on) (Schmidt et al., 2005), or with
the control vector pTOPO (pCR2.1-TOPO, Invitrogen). For
plasmid-bearing strains, growth media was always supplemented
with 50 µg/ml kanamycin.
Generation of Human
Monocytes-Derived Macrophages
Human monocytes were purified from buffy coat of healthy
donors (obtained from Fondazione IRCCS Ca’ Granda Ospedale
Maggiore Policlinico in Milan), by Ficoll density gradient
separation, and by positive selection using CD14+ selection
(CD14 Microbeads, Miltenyi Biotec). Monocytes were suspended
in complete RPMI medium (10% heat-inactivated FCS, 1 mmol/l
sodium pyruvate, 10 mmol/l non-essential amino acids, and
1% penicillin/streptomycin) supplemented with 0.2 µg/ml of
recombinant human macrophage colony stimulating factor (rh-
M-CSF, Miltenyi Biotec). CD14+ cells were seeded into 24-well
culture plates at a density of 2 × 105 and were incubated at 37◦C
in a humidified 5% CO2 atmosphere for 6 days.
Phagocytosis Assay
Efficiency of either LF82 or MG1655 phagocytosis by human
macrophages was determined using the gentamicin protection
assay (Glasser et al., 2001). Prior to addition of bacteria,
monocytes-derived macrophage (MDM) monolayers were
washed twice with 1× PBS, and the medium was replaced with
1 ml of complete RPMI medium without penicillin/streptomycin.
Bacteria, grown overnight in different conditions, were
washed and resuspended in complete RPMI medium without
penicillin/streptomycin. MDM were infected at a multiplicity
of infection (MOI) of 100 bacteria per macrophage. After a
10 min centrifugation at 1,000 g, monocytes were incubated 1 h
at 37◦C to allow internalization. Cell monolayers were washed
twice in PBS to remove extracellular bacteria and treated with
RPMI containing 20 µg/ml gentamicin (20-fold the MIC for
both LF82 and MG1655) for 1 h to kill non-internalized bacteria.
Subsequently, the monolayers were washed twice with PBS,
and cells were lysed by adding deionized water containing 1%
(vol/vol) Triton X-100 (Sigma) for 10 min, to release internalized
bacteria. To obtain a precise determination of the bacterial titer,
cell lysates were serially diluted, 100 µl from each dilution was
plated on LB agar plates, and CFU were determined after 24 h
growth at 37◦C by viable count.
Adherence and Invasion Assays
Adhesion and invasion of epithelial cells by bacterial strains
MG1655 and LF82, grown in different conditions, were
determined using the intestinal cell line HT29 as previously
described (Martin et al., 2004). HT29 cells were seeded into 24-
well tissue culture plates at 4× 105 cells per well and maintained
in complete RPMI medium until a confluent monolayer was
formed. Bacterial cells, grown in different conditions, were
washed and resuspended in complete RPMI medium without
penicillin/streptomycin, and used, at 7 × 106 bacteria/well, to
infect monolayers, which had previously been washed twice with
sterile PBS. Incubation was carried out for 3 h at 37◦C in complete
medium without penicillin/streptomycin in a humidified 5% CO2
atmosphere. To determine the total number of cell-associated
bacteria, corresponding to adherent and intracellular bacteria,
epithelial monolayers were washed three times with sterile PBS to
remove unattached bacteria and then lysed with deionized water
containing 1% (vol/vol) Triton X-100. To determine bacterial
invasion, epithelial monolayers, after being incubated 3 h with
bacteria and washed three times with PBS, were incubated for 1 h
in cell culture medium containing 20 µg/ml of gentamicin, to kill
extracellular bacteria and washed again with PBS. The intestinal
epithelial cells were then lysed with 1% Triton X-100 in deionized
water. The amount of intracellular bacteria recovered from the




HT29 cell monolayers on glass coverslips were infected with LF82
cultures, grown overnight in different conditions, washed and
resuspended as previously described. After 3 h incubation in
RPMI medium, cells were washed, fixed in 4% paraformaldehyde
(PF)/PBS, blocked in 2% FBS/PBS and stained with rabbit anti-
E. coli antibody (ab20640, Abcam 1:100) for 1 h. Coverslips were
then incubated with goat anti-rabbit Alexa Fluor 488 diluted
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1:500 (Invitrogen). Nuclei were stained with 4′,6-diamidino-2-
phenylindole (DAPI, Molecular Probes). Images were acquired
by a Nikon A1 laser scanning confocal microscopy using a 60×
oil immersion objective (NA 1.4). The Z-stacks were acquired
taking an image every 0.5 µm.
Outer Membrane Protein Isolation
Cell fractionation was performed as described previously
(Deflaun et al., 1994). Briefly, 250 ml cultures, grown in different
conditions for 18 h, were centrifuged at 4,000 g for 10 min
at 4◦C and washed with 5 ml 0.1 M phosphate buffer (PB)
pH 7.0. Cells were resuspended in 2 ml PB with addition of
100 µg/ml lysozyme and 1 mM EDTA pH 8.0 and incubated at
room temperature for 10 min. Cells were disintegrated using a
French Press and centrifuged as above to remove unbroken cells.
The low-speed centrifugation supernatant was then centrifuged
at 100,000 g for 1 h at 4◦C to separate the cytoplasm (supernatant)
and the membrane fraction (pellet). The pellet was resuspended
in 2 ml of 2% Sarkosyl in PB, left for 20 min at room temperature,
and centrifuged at 40,000 g at 10◦C for 10 min to remove
ribosomes and cytoplasmic proteins that were still associated with
the membrane fraction. The pellet was resuspended in 1 ml of
1% Sarkosyl, precipitated again for 20 min at room temperature,
and centrifuged as before, and the pellet, corresponding to outer
membrane proteins, was resuspended in 0.5 ml H2O. Protein
concentrations were determined using standard Bradford assay,
and 10 µg total proteins was loaded onto a 12% sodium dodecyl
sulfate-polyacrylamide gel (SDS-PAGE). Specific bands were
identified by matrix assisted laser desorption/ionization-time of
flight (MALDI-TOF) analysis of the peptide products after in-
gel trypsin digestion (Chen et al., 2000); performed by CEINGE,
University of Naples, Italy1.
Yeast Cell Aggregation Assay
Yeast aggregation was determined as described (Claret et al.,
2007). Commercial baker’s yeast (Saccharomyces cerevisiae) was
suspended in PBS (10 mg, dry weight/ml). Overnight bacterial
cultures, grown in various conditions, were resuspended in PBS
to an OD600 = 0.3. Equal volumes of fixed yeast cell suspension
and decreasing concentrations of E. coli suspension were mixed
in a 96-well plate. Aggregation was monitored visually, and the
titer was recorded as the last dilution of bacteria giving a positive
aggregation reaction.
Transmission Electron Microscopy
Overnight bacterial cultures, grown in various conditions, were
fixed and negatively stained with 1% ammonium molybdate on
carbon-Formvar copper grids as described (Claret et al., 2007).
Gene Expression Determination by
Real-Time PCR
For RNA isolation, strains were grown in various conditions
either at 28◦C or at 37◦C; for each gene tested, we determined
the timing of its maximal expression, choosing from: mid
1http://www.ceinge.unina.it/
log, onset of stationary phase (termed as “late log” in the
figures), or late stationary phase (Supplementary Figure 4 and
Figure 4A). Bacterial cells were harvested by centrifugation at
10,000 g for 5 min at 4◦C, and total RNA was extracted using
RNeasy Mini Kit (QIAGEN). RNA samples were checked by
agarose gel electrophoresis to assess lack of degradation, and
quantified spectrophotometrically. Genomic DNA was removed
by DNase I treatment. Reverse transcription was performed on
1 µg total RNA, along with negative control samples incubated
without reverse transcriptase. cDNA synthesis efficiency was
verified by electrophoresis on agarose gel in comparison to
negative controls. Real-time PCR was performed using the SYBR
Green PCR master mixture, and the results were determined
with an iCycler iQ Real-Time detection system (Bio-Rad).
Reaction mixtures (25 µl) included 0.1 µg cDNA and 300 nM
primers in the reaction buffer and enzyme supplied by the
manufacturer. Primer sequences are listed in Supplementary
Table 1. All reactions were performed in duplicate, including
negative control samples, which never showed significant
threshold cycles. A minimum of four experiments (two replicates
of two independent cultures) was performed. The relative
transcript amounts were determined using 16S rRNA as
the reference gene [(CtGene of interest − Ct16S) = 1Ct
value].
Biofilm/Adhesion Quantification
Biofilm formation was determined using the crystal violet (CV)
assay. Briefly, overnight bacterial culture, grown in various
conditions, were normalized at OD600 = 0.02 and incubated
in triplicates (200 µl/well) in a 96-well round bottom plate
for 16 h at 37◦C. After quantification of their OD600nm in a
plate reader, planktonic cells were removed and attached cells
were washed twice with sterile distilled water. A 200 µl of CV
solution (1%) was added for 20 min, then the plates were washed
twice, air dried, and biofilm/cell bound CV was dissolved in
96% ethanol for 10–15 min at room temperature. Finally, 100 µl
of the solubilized CV were transferred to a new 96-well flat
bottom plate containing 100 µl of distilled water and biofilm
formation was quantified at 550 nm in a plate reader (SS Read
200) using 96% ethanol in water as the blank. The adhesion
index was calculated as OD550 (CV)/OD600 (planktonic culture).
Since normalization of biofilm formation to the OD600nm of the
planktonic cultures might lead to incorrect estimation of the
actual number of bacterial cells, due to different cell morphology
or production of different extracellular polysaccharide (EPS)
amounts, we also determined the biofilm/planktonic cells ratio
by viable counts. These experiments confirmed in full the
data obtained using OD600nm for normalization (data not
shown).
Motility Assay
Bacterial cells were grown overnight in YESCA growth media,
with or without 8 µg/ml 6-MP, 0.2% glucose, or both, and
normalized to an OD600 = 1. For each culture, 3 µl were spotted
at the center of a motility agar plate in the same growth medium
used for overnight cultures, supplemented with 0.3% agar. LF82
showed very active motility, resulting in complete colonization of
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FIGURE 1 | Adhesion and internalization of AIEC-LF82 and non-pathogenic MG1655 strains within intestinal epithelial cells and human monocyte-derived
macrophages. (A) Growth curve of LF82 strain grown at 37◦C in YESCA medium supplemented with 6-mercaptopurine (6-MP, 2 µg/ml), glucose (GLU, 0.2%), or
both (GLU + 6-MP). (B,C) HT29 intestinal epithelial cell lines were infected with LF82 (black bars) or MG1655 (white bars) strains previously growth in YESCA
medium supplemented with 6-MP (2 µg/ml), glucose (GLU, 0.2%), or both (GLU + 6-MP). The number of adhered (B) or internalized (C) bacteria, to assess
adhesion and invasion, respectively, was determined as described in Section “Materials and Methods.” (D) Human MDM from healthy donors were infected with
LF82 (black bars) or MG1655 (white bars) strains previously growth in the presence of 6-MP (2 µg/ml), glucose (GLU, 0.2%), or both (GLU + 6-MP). The numbers of
bacteria internalized within macrophages were determined at 1 h post-infection. Results were expressed as numbers of CFU/ml and represented as mean ± SEM of
triplicate experiments. Data were analyzed by Student’s t-test: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
the agar plate after an overnight growth. Reduction of incubation
time to 8 h at 37◦C allowed a more precise measurement of the
bacterial halo diameters.
Total EPS Isolation and Quantification,
and Cellulose Determination
For EPS preparation, 50–100 ml of overnight cultures of bacteria
grown in different conditions were centrifuged for 25 min at
5,000 rpm and resuspended in sterile PBS to an OD600 = 20.
Normalized sample was washed twice in PBS 1×, resuspended
in 1 ml of freshly made 2% EDTA pH 8.0 (in H2O) and incubated
for 4 h at 4◦C with slow orbital agitation. Before and after
incubation with 2% EDTA, 10 µl of bacterial suspensions were
serially diluted and plated on LB agar plates to verify the effect
of EDTA treatment on cell survival. After a 4 h incubation
in 2% EDTA, the suspension was centrifuged for 25 min at
5,000 rpm, and the supernatant was collected and filtered
at 0.45 µm. Total sugar quantification was performed using
the phenol-H2SO4 determination method (Rossi et al., 2014).
Assessment of cellulose production was performed on solid
media supplemented with the fluorescent dye Calcofluor (CF):
overnight cultures adjusted to an OD600 = 0.5 and spotted on
media supplemented with 0.005% CF after autoclaving. Bacteria
were grown for 20 h at 37◦C; phenotypes were better detectable
after a further 24–48 h incubation at 4◦C.
Statistical Analysis
All experiments were performed at least three times. Statistical
analysis was performed with Prism 5 software (GraphPad
Software, La Jolla, CA, United States). Student’s t-tests for
unpaired or paired samples were used to evaluate differences.
RESULTS
6-Mercaptopurine and Glucose
Drastically Reduce the Invasion of
Intestinal Epithelial Cells and
Phagocytosis of AIEC-LF82 Strain
In order to assess whether 6-MP could affect AIEC virulence,
we performed human cell adhesion and invasion assays using
the CD-associated AIEC strain LF82. LF82 was grown overnight
in the peptone-based, complex YESCA medium (see section
“Materials and Methods”); this medium, in addition to providing
a variety of carbon and nitrogen sources similar to those
available in the host, can promote efficient production of
several adhesion factors in E. coli (Hammar et al., 1995; Rossi
et al., 2014). When required, 6-MP was added at 2 µg/ml.
At this concentration, 6-MP does not affect LF82 growth rate
(Figure 1A), which is inhibited, albeit partially, even at 6-MP
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concentrations well below the MIC of 64 µg/ml (Supplementary
Figure 1).
Moreover, we grew LF82 in YESCA medium supplemented
with 0.2% glucose, a concentration at which AIEC can be
transiently exposed in the ileum, in order to evaluate the
importance of glucose sensing, and inhibition of cAMP
biosynthesis, on AIEC virulence. Finally, to assess the
combined inhibition of c-di-GMP and cAMP signaling on
LF82 pathogenesis, we grew it in the presence of both 6-MP
and glucose. LF82 viability and growth rate were identical in all
growth conditions tested (Figure 1A).
LF82 was grown overnight in different growth conditions,
washed and normalized to the same bacterial concentrations
in RPMI, prior to their incubation with human cells. Thus,
bacteria were exposed to different growth media as a pre-
conditioning step only, while adhesion and invasion assays
were only performed in the RPMI medium. Neither intestinal
epithelial cells HT29 nor human MDM were thus ever exposed
to 6-MP in any of our experiments. The E. coli laboratory strain
MG1655, grown in the same variety of conditions as LF82, was
used as a non-pathogenic control in adhesion, invasion, and
phagocytosis experiments.
Our data confirmed the higher proficiency of LF82 strain
to adhere to intestinal epithelial cells compared to non-
pathogenic strain MG1655 (Martin et al., 2004; Figure 1B).
Notably, for bacteria pre-conditioned with 6-MP, we observed
a significant reduction in the number of epithelial-adhering
bacteria for LF82 (2.1-fold reduction) strain, but not for
MG1655. Interestingly, the adhesion capacity of LF82 was also
reduced by roughly twofold in the presence of glucose, and
even further (3.37-fold in comparison to YESCA medium)
when cells had been grown overnight in the presence of
both 0.2% glucose and 2 µg/ml 6-MP (Figure 1B). On
the contrary, attachment of E. coli MG1655 to epithelial
cells was unaffected, or even slightly increased, for cells
pre-grown in the presence of either 6-MP or glucose, thus
suggesting that both these molecules can target the production
of AIEC-specific adhesion determinants, although their
combination resulted in impaired cell adhesion also in MG1655
(Figure 1B).
LF82 cells grown overnight in the presence of either 2 µg/ml
6-MP or 0.2% glucose showed reduced invasion of HT29
cells; addition of both glucose and 6-MP to YESCA medium
showed an additive effect, resulting in further reduction of
cell invasion (Figure 1C). These results mirror the outcome of
adhesion assays, strongly suggesting that decrease in invasion
is simply a consequence of reduced adhesion: indeed, the
ratio of internalized/adhered LF82 cells was very similar in
all cases (data not shown). Unlike LF82, the E. coli MG1655
laboratory strain failed to invade epithelial cells in any of the
conditions tested, consistent with its non-pathogenic nature
(Figure 1C).
To confirm the results obtained by bacterial cell counting
(Figure 1), we also determined adhesion to human
epithelial cells by LF82 pre-grown in different conditions
using immunofluorescence assays followed by confocal
microscopy as described in Section “Materials and Methods.”
Immunofluorescence assays (Figure 2) showed a clear decrease
in attachment of LF82 pre-grown in the presence of 6-MP,
glucose, or both, in agreement with quantitative assessment
by cell counting. We could not detect any adhesion of the
LF82 strain to the glass slide in the absence of the epithelial
cell monolayer in our experimental conditions; likewise, in
monolayers not grown to 100% confluence, bacterial attachment
was only observed in the areas covered by epithelial cells
(Supplementary Figure 2).
Interestingly, the selective inhibitory effect of 6-MP on AIEC
was also observed in phagocytosis experiments using MDM
(Figure 1D). Indeed, in the presence of either 2 µg/ml 6-MP
or 0.2% glucose, we observed significantly lower number of
internalized LF82 bacteria within MDM after 1 h of infection,
a reduction similar to what observed in the adhesion and
invasion experiments with HT29 cells. Unlike for epithelial cells,
however, the combination of glucose and 6-MP did not show any
synergistic effects on phagocytosis by MDM (Figure 1D). Neither
6-MP nor glucose significantly prevented MG1655 uptake by
MDM, again suggesting inhibition of AIEC cellular processes.
Altogether, these results suggest that 6-MP selectively affects
AIEC pathogenesis, by reducing its ability to adhere to intestinal
epithelial cells and its uptake by macrophages, both processes able
to trigger the overly inflammatory response characteristic of CD.
FIGURE 2 | Maximum projection of Z-stack sections, obtained by confocal
microscopy, of HT29 cell monolayers incubated with AIEC LF82. LF82 strain
was pre-grown overnight either in YESCA medium (YESCA) or in YESCA
supplemented with 2 µg/ml 6-mercaptopurine (6-MP), 0.2% glucose (GLU),
or both (GLU + 6-MP) prior to a 3-h incubation with epithelial cells in RPMI
medium. Cell nuclei (stained by DAPI) are shown in blue and LF82 in green.
Scale bar: 20 µm. The main picture shows the view from the top, with the
side views (YZ – right) and (XZ – bottom) showing sagittal sections of the
infected monolayers.
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FIGURE 3 | Analysis of cell surface-associated proteins and yeast
agglutination assay. (A) SDS-PAGE of outer membrane proteins from LF82
grown in different conditions. The position of molecular weight markers is
shown to the right. Bands were excised and the proteins identified with
certainty by MALDI-TOF are indicated in the figure. (B) Ability of type 1 pili to
bind D-mannose residues as determined by a yeast aggregation test. AIEC
LF82 and MG1655 were growth overnight in YESCA supplemented with
6-MP (2 µg/ml), glucose (GLU, 0.2%), or both (GLU + 6-MP). A fixed amount
of yeast cells (S. cerevisiae) suspension and decreasing concentrations of
bacteria were mixed, and the loss of the ability to form homogenous
aggregation was used as the read-out for impaired type 1 pili-yeast
interaction. Aggregation was monitored visually, and the titer was recorded as
the last dilution of bacteria giving a positive aggregation reaction as indicated
by circles in the figure.
Expression of Cell Adhesion
Determinants at Phenotypic Levels
In order to identify which LF82 cell adhesion determinants might
be affected by pre-growth in the presence of 6-MP, or in glucose,
we observed overnight cultures grown in different conditions
with transmission electron microscopy (TEM), using negative
staining. TEM analysis did not show any significant changes in
production of cell appendages such as flagella, a known virulence
determinant in AIEC, in the different growth conditions tested
(Supplementary Figure 3). To analyze further the production of
possible cell adhesion factors, we isolated outer membrane and
cell surface-associated proteins from LF82 overnight cultures.
Cell surface-associated proteins were separated by SDS-PAGE
(Figure 3A) and proteins differently expressed in different
conditions, as determined by band intensity, as well as selected
markers, were identified by MALDI-TOF. The main differences
in the pattern of cell surface associated proteins were observed
between cultures grown either in the absence or in the presence
of glucose: MALDI-TOF analysis showed a sharp decrease in
the expression of the outer membrane-associated OmpA, MipA,
and FimA proteins in LF82 growing in glucose-supplemented
YESCA medium, while, in contrast, the NlpE outer membrane
lipoprotein was more expressed in the presence of glucose.
In agreement with electron microscopy observations, flagellin,
the product of the fliC gene, was produced at similar levels
regardless of all growth conditions tested. Differential expression
of the OmpA, MipA, and NlpE proteins is consistent with the
lack of cAMP synthesis in glucose-supplemented media and
the consequent inhibition of the cAMP/CAP protein regulatory
network, which positively controls the ompA and mipA genes
and represses nlpE (Movva et al., 1981; Tan et al., 2001; Raghavan
et al., 2011).
Among the proteins downregulated in the presence of glucose,
the FimA protein, the main component of type 1 fimbriae, is
the most directly involved in adhesion to eukaryotic cells and
it is an important determinant for AIEC virulence (Boudeau
et al., 2001; Dreux et al., 2013). To verify further that production
of type 1 fimbriae was affected in glucose supplementation, we
performed a yeast agglutination assay, which relies on type 1 pili
binding of the mannose receptors on S. cerevisiae cell membrane.
In agreement with the results of the SDS-PAGE analysis, yeast
aggregation was eightfold more efficient when LF82 cells grown
in the absence of glucose were used (Figure 3B).
Growth in the presence of 6-MP resulted in slight changes
in outer membrane-associated protein expression pattern
(Figure 3A): however, MALDI-TOF analysis of these bands
were inconclusive and did not allow us to identify any possible
adhesion factor whose expression was clearly affected by 6-MP.
Despite showing similar levels of FimA expression, LF82 cells
grown in 6-MP-supplemented YESCA medium showed a twofold
decrease in its ability to induce yeast agglutination (Figure 3B),
in line with their reduced ability to attach to human epithelial
cells (Figure 1B).
6-MP and Glucose Affect Gene
Expression of Different Adhesion and
Virulence Determinants in AIEC
In order to investigate the possible inhibition mechanisms of
LF82 adhesion to epithelial cells and uptake by macrophages
by either 6-MP or exogenous glucose, we determined the
effects of either molecule on the expression of genes involved
in AIEC virulence and/or encoding cell surface-associated
factors, using quantitative RT-PCR (qRT-PCR). In particular,
we investigated whether inhibition of type 1 pili production
by glucose supplementation takes place at the transcription
level, by testing fimA gene expression levels. In addition, we
studied the lpfA gene, encoding the main subunit of long polar
fimbriae, and the ibeA gene, both factors involved in epithelial cell
invasion by AIEC (Barnich et al., 2003; Chassaing and Darfeuille-
Michaud, 2013; Cieza et al., 2015). In addition, we also studied
the expression of the csgB and csgD genes, coding respectively for
the minor subunit of curli fibers (thin aggregative fimbriae) and
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for the CsgD protein, the master regulator of curli and cellulose
production (Romling et al., 2000; Zogaj et al., 2001). Curli fibers
promote internalization of E. coli in several eukaryotic cell lines
(Gophna et al., 2001), and their expression is strongly impaired by
6-MP in E. coli MG1655 via inhibition of c-di-GMP biosynthesis
(Antoniani et al., 2013).
In order to better assess possible inhibition of gene
expression by either 6-MP or glucose, we performed preliminary
experiments aimed at establishing the timing of maximal
expression of the genes of interest. To this aim, we determined
expression levels in different growth phases, namely, during
exponential growth (mid log), at the onset of stationary
phase (late log), and in late stationary phase (Figure 4A and
Supplementary Figure 4). Transcription of csg genes is inhibited
at 37◦C in most enterobacteria (Romling et al., 2000), including
several pathogenic E. coli strains (Bian et al., 2000). For this
reason, in order to have a more complete assessment of gene
expression levels, we carried out qRT-PCR experiments on
cultures grown at both 28 and 37◦C. Expression timing was very
variable, with fliC peaking in exponential phase, csgD at the onset
of stationary phase, and csgB showing highest expression levels
at the onset of stationary phase in YESCA medium and in late
stationary phase in YESCA supplemented with 0.2% glucose.
Expression of fimA, lpfA, and ibeA was less stringently dependent
on growth phase, and remained comparable during exponential
growth and at the transition into stationary phase, while being
reduced in late stationary phase (Supplementary Figure 4, and
data not shown). Neither lpfA nor ibeA showed any significant
changes in expression levels regardless of presence of exogenous
glucose, or exposure to 6-MP (Supplementary Figure 5, and data
not shown). Growth temperature did not significantly change
gene expression timing, but strongly affected expression levels
of csg and fim genes (Figure 4). In particular, transcription of
csgB, the first gene of the csgBAC operon encoding the curli
fibers structural subunits, was not detectable in YESCA medium
at 37◦C (Figure 4C). Both 6-MP and glucose supplementation
strongly inhibited transcription of both csgD and csgB at 28◦C,
consistent with inhibition of c-di-GMP by 6-MP and of cAMP
by glucose, respectively. Indeed, both signal molecules are
necessary for full activation of the csgD gene (Zheng et al., 2004;
Sommerfeldt et al., 2009), and, in turn, of the csgBAC operon.
Opposite to csg genes, the fimA and the lpfA genes are
more efficiently transcribed (almost 50-fold) at 37◦C (Figure 4D
and Supplementary Figure 4), suggesting that the production
of curli and fimbrial structures is inversely regulated by the
temperature, allowing prevalent production of either adhesion
factor in different environmental conditions. 6-MP does not
significantly affect fimA transcription, which is in contrast
strongly impaired in glucose-supplemented YESCA medium
(Figure 4D), in agreement with SDS-PAGE analysis and yeast
agglutination assays (Figure 3). Thus, presence of exogenous
glucose strongly impairs transcription of both curli and type 1
pili, arguably the two main adhesion factors in E. coli, consistent
with a reduced interaction with eukaryotic cells of LF82 grown
overnight in glucose-supplemented medium (Figure 1B).
In the laboratory strain MG1655, fliC expression is
downregulated in glucose-supplemented media, coherent
with its cAMP activation via the class I flagellar regulator
FlhDC (Zhao et al., 2007) (Supplementary Table 2). Conversely,
in the LF82 strain, fliC expression was slightly increased in
the presence of 0.2% glucose (Figure 4E), consistent with the
results of TEM observations and SDS-PAGE analysis showing
no inhibition of flagellar production in glucose-supplemented
medium (Supplementary Figure 3 and Figure 3A). Our results
strongly suggest loss of flagellar regulation by the cAMP/CAP
system in AIEC, possibly as part of a pathoadaptive mechanism.
Exposure to 6-MP resulted in a weak (ca. twofold), albeit
reproducible, downregulation of fliC transcription, particularly
at 37◦C (Figure 4E).
6-MP Inhibits Both Biofilm Formation
and Flagellar Motility in LF82
Downregulation of csg gene expression in LF82 confirms
our previous results in MG1655 (Antoniani et al., 2013),
strongly suggesting inhibition of c-di-GMP by 6-MP. However,
inhibition of csgD gene expression by 6-MP is not detectable
at 37◦C (Figure 4B), thus making unclear whether, at this
temperature, inhibition of c-di-GMP-dependent synthesis is the
main mechanism of action of 6-MP.
As direct measurement of c-di-GMP in bacterial cell is
not straightforward, due to its extremely low intracellular
concentrations, we tested the effects of 6-MP on cell processes
influenced by c-di-GMP, such as biofilm formation, EPS
production and flagellar motility. In order to verify the effects
of c-di-GMP on such processes in AIEC, we transformed
LF82 with plasmids carrying either the adrA gene (encoding a
diguanylate cyclase), or the dosP gene (encoding a c-di-GMP
phosphodiesterase), in order to perturb intracellular c-di-GMP
concentrations. qRT-PCR experiments confirmed that both adrA
and dosP were transcribed at very high levels in LF82 transformed
with the respective plasmids, in YESCA medium with or without
glucose supplementation (Supplementary Figure 6).
LF82 biofilm formation on polypropylene microtiter plates
was only very slightly affected by the presence of exogenous
glucose (Figure 5), suggesting that type 1 pili, whose production
is inhibited by glucose (Figure 4D), do not play a significant
role in this process. In contrast, biofilm formation was impaired,
weakly but significantly, by 6-MP (Figure 5A), consistent with
possible c-di-GMP inhibition (Romling et al., 2013); indeed,
overexpression of the c-di-GMP phosphodiesterase DosP led
to a similar result. However, AdrA overexpression resulted in
an even stronger reduction in LF82 adhesion, suggesting that
an increase in intracellular c-di-GMP can also negatively affect
biofilm formation (Figure 5B). This apparently counterintuitive
result might depend on AdrA-dependent stimulation of cellulose
production, as this EPS, while being a positive determinant for
cell adhesion, can also impair adhesion to solid surfaces when
overproduced (Gualdi et al., 2008). Indeed, determination of
cellulose production on Calcofluor-supplemented plates clearly
shows that both treatment with 6-MP and DosP overexpression
impair cellulose production, which is, conversely, strongly
induced by AdrA (Figures 6A,B). As cellulose production is
dependent on c-di-GMP production (Figure 6B; Zogaj et al.,
2001; Da Re and Ghigo, 2006) this result would suggest
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FIGURE 4 | Expression of genes encoding main LF82 extracellular factors. (A) LF82 growth curve in YESCA medium at 37◦C. A single, representative experiment is
shown. Points 1, 2, and 3 indicate the time points (mid log, late log, and stationary phase) at which samples were taken for RNA extraction and determination of
expression levels for the csgD, csgB, fimA, fliC, lpfA, and ibeA genes. Arrows indicate the time points at which the highest expression levels for each gene was
observed, and which were used to study the effects of 6-MP and exogenous glucose. See Supplementary Figure 4 for further details. Expression of csgD (B), csgB
(C), fimA (D), and fliC (E) in different growth media, and at either 28◦C (black bars) or 37◦C (gray bars) was determined by qRT-PCR on RNA extracted at the time
points indicated in panel (A). For fimA, the time point 2 (late log) was taken. 16S RNA transcript was used as reference gene. 1Ct values between the genes of
interest and 16S RNA were set at 1 for values measured in YESCA medium at 28◦C, and transcript levels in other growth conditions are expressed as relative values.
The 1Ct values were csgD = 8.4; csgB = 4.85; fimA = 11.33; fliC = 3.38. Data were analyzed by Student’s t-test: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
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FIGURE 5 | Quantitative evaluation of biofilm in crystal violet (CV) assay. (A) Biofilm formation by LF82 strain grown in various conditions (YESCA alone or
supplemented with 2 µg/ml 6-MP, or with 0.2% glucose, or both); (B) biofilm formation by LF82 strains overexpressing either AdrA or DosP, or harboring the control
vector pTOPO, in the presence or absence of 0.2% glucose. The adhesion index was determined after 16 h of growth at 37◦C, calculated as OD550 (CV)/OD600
(planktonic culture) and expressed as mean ± SEM of triplicate experiments. Data were analyzed by Student’s t-test: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
FIGURE 6 | Cellulose and extracellular polysaccharide production of LF82. Cellulose visualization on Calcofluor-supplemented media. (A) LF82 was grown at 37◦C
for 24 h in YESCA supplemented with 8 µg/ml 6-MP, or 0.2% glucose, or both; (B) LF82 strains overexpressing either AdrA or DosP, or harboring the control vector
pTOPO, were grown at 37◦C for 24 h in YESCA medium in the presence or absence of 0.2% glucose. Determination of overall extracellular polysaccharide
production. (C) LF82 grown in YESCA, alone or supplemented with 2 µg/ml 6-MP, or 0.2% glucose, or both (D) LF82 strains overexpressing either AdrA or DosP, or
harboring the control vector pTOPO, in the presence or absence of 0.2% glucose. Data were analyzed by Student’s t-test: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
that 6-MP can target c-di-GMP signaling in AIEC grown at
37◦C.
In terms of overall EPS production, however, availability of
extracellular glucose, rather than c-di-GMP, appears to play the
main role (Figure 6C), likely by increasing intracellular UDP-
glucose concentrations available for EPS biosynthesis. Indeed,
while overexpression of either AdrA or DosP significantly
impacts total EPS production in LF82 grown in YESCA
medium, addition of glucose completely supersedes their effects
(Figure 6D).
Finally, we tested LF82 swimming motility, a process
negatively regulated by c-di-GMP in enterobacteria (Romling
et al., 2013), in the presence of 6-MP and in LF82 strains
overexpressing AdrA and DosP. In line with an increase of
intracellular c-di-GMP concentrations, AdrA overexpression
resulted in a clear reduction in swimming motility, particularly
in the presence of glucose (Figure 7B). Unexpectedly, however,
treatment of LF82 with 6-MP also resulted in a sharp decrease
in motility (Figure 7A), inconsistent with inhibition of c-di-
GMP production. Addition of exogenous glucose also negatively
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FIGURE 7 | Swimming motility of LF82 strain. Flagellar motility assays. (A) LF82 in YESCA/0.3% agar medium supplemented with 6-MP (8 µg/ml), glucose (0.2%),
alone or both (GLU + 6-MP). (B) LF82 strains overexpressing either AdrA or DosP, or harboring the control vector pTOPO, in YESCA medium, alone or
supplemented with glucose (0.2%). Results were expressed as the halo diameter (cm) and represented as mean ± SEM of triplicate experiments. Data were
analyzed by Student’s t-test: ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
affects motility, albeit at a lesser extent than 6-MP: since
glucose does not affect flagellar gene expression in LF82
(Figure 4E), this inhibition is likely to take place via increased
EPS production (Figure 6C), known to interfere with flagellar
motility (Zorraquino et al., 2013).
DISCUSSION
6-Mercaptopurines, in particular the pro-drug azathioprine,
are widely used as immunomodulators in the treatment of
CD. Azathioprine, upon metabolic activation in the intestinal
mucosa, can block T-cell activation and proliferative processes
in macrophages and gut epithelial cells through inhibition
of Rac1 and Rac2 proteins (Tiede et al., 2003; Marinkovic
et al., 2014). In addition to its anti-inflammatory properties,
6-MP have also been shown to possess antimicrobial activity
against M. paratuberculosis (Shin and Collins, 2008) and
Campylobacter jejuni (Liu et al., 2017), and to inhibit c-di-
GMP synthesis and cell adhesion in E. coli (Antoniani et al.,
2013). In this work, we investigated whether 6-MP could
modulate bacterial virulence in AIEC, an important pathobiont
strongly correlated with CD, via inhibition of c-di-GMP
signaling pathways, thus contributing to its anti-inflammation
activity.
To this aim, we have carried out experiments testing the
ability of 6-MP to inhibit epithelial cell adhesion and invasion by
the AIEC strain LF82, important pathogenic processes directly
involved in the onset of chronic inflammation in CD (Eaves-
Pyles et al., 2008). In order to clearly distinguish between effects
on bacterial virulence and on inhibition of Rac1/Rac2 in human
cells, LF82 cultures were treated with 6-MP exclusively prior to
incubation with epithelial cells, which were thus never exposed
to 6-MP in our experiments. 6-MP concentrations used in
these experiments did not perturb LF82 growth rate or total
biomass in overnight cultures (Figure 1A and Supplementary
Figure 1), indicating that neither viability nor the overall
physiological state of the bacterium were affected, and were
well below therapeutic doses administered during CD treatment
(Pearson et al., 1995). Our experiments clearly demonstrate that
pre-conditioning of LF82 overnight cultures with 6-MP was
sufficient to impair its ability to adhere (Figures 1B, 2), and
consequently to invade (Figure 1C), epithelial cells. Another
important virulence mechanism described for AIEC is its ability
to survive and replicate within macrophages (Glasser et al.,
2001). Our results show that uptake of 6-MP-treated LF82 by
human MDMs was likewise impaired (Figure 1D), strongly
suggesting that exposure of AIEC to 6-MP can induce a long-
lasting inhibition of its cell adhesion determinants involved in
interaction with different human cell types. Our results strongly
demonstrate that 6-MP can inhibit adhesion to epithelial cells,
and consequently their invasion, by AIEC, and impair its uptake
by macrophages, exclusively targeting bacterial cell processes.
As internalization into human epithelial cells, and survival in
macrophages, represent strong triggers for CD inflammation
(Eaves-Pyles et al., 2008; Bringer et al., 2012), inhibition of
bacterial adhesion and phagocytosis might play a crucial role in
anti-inflammatory activity of 6-MP. At the same time, however,
reduction of AIEC uptake might result in reduced clearance
of these bacteria in CD patients treated with 6-MP, which in
the long term could undermine the beneficial effects of these
drugs.
Unlike for LF82, exposure to 6-MP of E. coli MG1655
did not impair its ability either to attach to epithelial cells
or to be phagocytized by human macrophages (Figure 1),
suggesting that interaction between MG1655 and human
cells might rely on a different set of cell adhesion factors,
consistent with the non-pathogenic nature of this bacterium.
Differences in cell adhesion regulation between AIEC and
non-pathogenic E. coli are also highlighted by the effects
of extracellular glucose on interaction with human cells:
indeed, overnight growth in glucose-supplemented medium
resulted in opposite effects in LF82 and MG1655 strains,
somehow mirroring exposure to 6-MP (Figure 1). We
hypothesized that the modulation of adhesion determinants
in AIEC upon exposure to 6-MP and/or glucose might be
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due to the impairment of cell signaling pathways specific for
LF82.
In E. coli, availability of exogenous glucose affects biosynthesis
of the nucleotide-derived signal molecules cAMP. Due to its
ability to inhibit de novo purine biosynthesis (Ha et al., 1990), we
hypothesized that 6-MP might also affect cAMP production in
LF82. However, at the concentrations used in our experiments,
6-MP does not affect cAMP-dependent regulation in LF82 as
indicated by lack of differential expression in cAMP-dependent
outer membrane proteins (Figure 3A), and had a different
impact to glucose on fimA expression (Figures 3A, 4D), thus
suggesting that the two molecules target different signaling
pathways.
Glucose inhibition of epithelial cell adhesion by AIEC, and
its uptake by macrophages, possibly via inhibition of fimA
expression, indicates that, unlike for other pathogenic bacteria
(Munson, 2013; Daddaoua et al., 2014; Rossi et al., 2016),
sensing of exogenous glucose availability would dampen AIEC
virulence. This observation would be consistent with the ability
of AIEC to cause local infection and inflammation, rather than
extending to the more glucose-rich interstitial tissues and to the
bloodstream.
Both 6-MP and exogenous glucose strongly downregulate
transcription of the curli-related csgB and csgD genes, in line
with inhibition of c-di-GMP and cAMP, respectively. Curli fibers
can promote E. coli internalization in human epithelial cells
(Gophna et al., 2001); however, in LF82, the csgD regulatory
gene, and even more so the csgB gene, encoding the minor
structural subunit of curli, were strongly downregulated at
37◦C (Figures 4B,C), thus suggesting that curli do not play
a role in adhesion/invasion processes in AIEC. In contrast,
cellulose production was clearly detectable also at 37◦C, and
was strongly inhibited by 6-MP, but not by exogenous glucose
(Figure 6A), consistent with its strong dependence on c-di-
GMP (Figure 6B). Remarkably, cellulose can promote adhesion
to epithelial cells in enterobacteria (Monteiro et al., 2009),
possibly suggesting that 6-MP inhibition of LF82 adhesion to
human cells might be mediated, at least in part, by reduced
cellulose production. Notably, however, while cellulose is strictly
dependent on c-di-GMP, overall EPS production is more
affected by exogenous glucose (Figures 6C,D), probably via
stimulation of the EPS biosynthetic pathways by increased
glucose availability.
In addition to cellulose biosynthesis, c-di-GMP strongly
impacts biofilm formation and cell motility, which, in turn, can
affect virulence and interaction with host cells in many bacteria.
As already observed for cellulose and EPS production, 6-MP and
exogenous glucose impacted biofilm formation in different ways:
6-MP led to a significant reduction of biofilm formation, which
conversely showed little or no inhibition by glucose (Figure 5).
Again, this result would point to the inhibition of c-di-GMP
biosynthesis by 6-MP, as also observed with DosP overexpression
(Figure 5B), and in line with the role of this signal molecule in
biofilm formation. Although biofilm formation was even more
strongly affected by AdrA overexpression (Figure 5B), this effect
might be ascribed to cellulose overproduction, which is known to
negatively affect adhesion to solid surfaces (Gualdi et al., 2008).
Surprisingly, LF82 treated with 6-MP displayed a sharp
decrease in swimming motility, inconsistent with c-di-
GMP inhibition (Figure 7). This result strongly suggests
that, in addition to c-di-GMP inhibition, 6-MP is able to
interfere with cell signaling processes, possibly via inhibition
of de novo purine synthesis (Ha et al., 1990), which might
in turn affect nucleotide-derived signal molecules other
than c-di-GMP. Inhibition of swimming motility by 6-MP
might play a significant role in downplaying LF82–host
cell interaction, as it was shown that non-motile AIEC fliC
mutant strains have a significantly reduced ability to invade
intestinal epithelial cells (Eaves-Pyles et al., 2008). Inhibition
of flagellar motility might also be the main mechanism
by which 6-MP negatively affects biofilm formation, as
flagella have been shown to be necessary for initial surface
colonization by several Gram-negative bacteria (Pratt and Kolter,
1998).
CONCLUSION
In conclusion, our results have highlighted a novel, additional
role for 6-MP, targeting bacterial virulence rather than human
cells. In particular, micromolar concentrations of 6-MP can
prevent AIEC adhesion to human epithelial cells and uptake
by macrophages, likely via inhibition of cellulose production
and cell motility. Since 6-MP impairs c-di-GMP biosynthesis
(Antoniani et al., 2013), targeting this signal molecule could
be an interesting strategy to hamper AIEC virulence. Although
AIEC is not the sole responsible for the onset of chronic
inflammation of CD, and our study did not tackle the
full complexity of this disease, our results allow us to
propose that targeting virulence factors of CD-related bacterial
pathobiont species might represent a valuable therapeutic
strategy in CD remission. Indeed, while 6-MP remain an
integral part of disease management in IBD patients, it
has been reported that a small, albeit clear, association
exists between non-melanoma skin cancer and lymphoma
with long-term thiopurines usage (Beaugerie et al., 2009;
Peyrin-Biroulet et al., 2011), as well as a moderate-to-severe
relapse rate after thiopurines withdrawal (Kennedy et al.,
2014). Thus, novel molecules targeting virulence factors of
pathobionts, while leaving not only eukaryotic cells, but also
commensal and beneficial microorganisms unaffected, would be
an extremely useful therapeutic strategy in treatment of CD
patients.
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